Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer

Clinical trial NCT00614653 · COMPLETED

Trial details

NCT number: NCT00614653
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2008-01-01
Primary completion: 2016-07-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.